Effect of roxadustat on lowering blood lipids in peritoneal dialysis patients with anemia

Objectives To observe the effect of roxadustat on lowering blood lipids in peritoneal dialysis (PD) patients beyond treating anemia.Methods In a prospective, multicenter clinical study, we randomly assigned (in a 1:1 ratio) 100 PD patients who had received erythropoiesis-stimulating agent therapy fo...

Full description

Bibliographic Details
Published in:	Renal Failure
Main Authors:	Tian Xu, Yilin Ruan, Na Liu, Yi Wang, Xiujuan Zang, Yuhua Ma, Hualin Qi, Xiuhua Mi, Geping Yu, Chunyan Zhang, Xiaomin Huang, Jingyuan Xie, Nan Chen, Hong Ren
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Subjects:	Roxadustat blood lipids peritoneal dialysis anemia iron metabolism
Online Access:	https://www.tandfonline.com/doi/10.1080/0886022X.2025.2460726

Similar Items

A retrospective study on the efficacy of Roxadustat in peritoneal dialysis patients with erythropoietin hyporesponsiveness
by: Jie Liu, et al.
Published: (2024-05-01)

Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis
by: Zhikai Yang, et al.
Published: (2022-03-01)

Evaluating the effect of Roxadustat on ventricular repolarization in patients undergoing peritoneal dialysis
by: Yangyang Zhang, et al.
Published: (2023-10-01)

Impact of roxadustat on anemia management in infected patients undergoing long-term dialysis: a retrospective cohort analysis
by: Lulu Wang, et al.
Published: (2025-10-01)

The efficacy and safety of roxadustat for anemia in patients with dialysis-dependent chronic kidney disease: a systematic review and meta-analysis
by: Qiaoqiao Zhou, et al.
Published: (2023-12-01)

A nomogram for predicting the risk of treatment failure of roxadustat in peritoneal dialysis with renal anemia
by: Jiangqing Fan, et al.
Published: (2024-04-01)

The role of roxadustat in chronic kidney disease patients complicated with anemia
by: Jie Liu, et al.
Published: (2023-03-01)

Roxadustat for ESA‐Hyporesponsive Renal Anemia in a 13‐Year‐Old on Hemodialysis: Case Report and Mini‐Review
by: Meng Zhang, et al.
Published: (2025-10-01)

Comparison between the influence of roxadustat and recombinant human erythropoietin treatment on blood pressure and cardio-cerebrovascular complications in patients undergoing peritoneal dialysis
by: Shuiqin Cheng, et al.
Published: (2023-06-01)

Safety of Roxadustat in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis
by: Patricia Martínez-Miguel, et al.
Published: (2025-10-01)

Roxadustat for the Treatment of Early Post-Transplantation Anemia
by: Louis Guenal, et al.
Published: (2025-10-01)

Roxadustat: Not just for anemia
by: Xiaoyu Zhu, et al.
Published: (2022-08-01)

Roxadustat on Renal Anemia with Macroinflammation: A Retrospective Cohort Study
by: Yan Tu, et al.
Published: (2024-03-01)

Roxadustat for Patients with Posttransplant Anemia: A Narrative Review
by: Xiaoxiao Tang, et al.
Published: (2023-11-01)

Randomized Trial of Lower-Dose Roxadustat Efficacy and Safety in Non–Dialysis-Dependent CKD-Associated Anemia
by: Ping Li, et al.
Published: (2025-04-01)

Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease
by: Keiji Hirai, et al.
Published: (2023-02-01)

Comparison of anemia in elderly patients with peritoneal dialysis and hemodialysis
by: CHENG Li, et al.
Published: (2018-01-01)

Influencing factors of clinical efficacy of roxadustat among hemodialysis patients
by: Wenhui Wu, et al.
Published: (2024-12-01)

Anemia Is a Predictor of Withdrawal from Peritoneal Dialysis in Stable Peritoneal Dialysis Patients
by: Kenta Torigoe, et al.
Published: (2025-04-01)

Roxadustat for the treatment of anemia in patients with chronic kidney disease: a Meta-analysis
by: WANG Rui, et al.
Published: (2019-01-01)

Thyroid function analysis after roxadustat or erythropoietin treatment in patients with renal anemia: a cohort study
by: Xiaomeng Zheng, et al.
Published: (2023-12-01)

Clinical observation of Shengxuening tablets in the treatment of renal anemia in maintenance peritoneal dialysis
by: ZHANG Juan, et al.
Published: (2016-01-01)

Research progress on roxadustat treatment for renal anemia
by: HU Bao-li, HU Bin
Published: (2022-09-01)

Hemoglobin level and its related factors in patients undergoing peritoneal dialysis
by: Liu Zhao-xia, et al.
Published: (2021-01-01)

Roxadustat in CKD and transplant patients: A new era in anemia management
by: Muhammad Tassaduq Khan, et al.
Published: (2025-03-01)

The Efficacy and Safety of Roxadustat for Anemia in Hemodialysis Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials
by: Yunling Geng, et al.
Published: (2024-11-01)

Roxadustat: Do we know all the answers?
by: Qiu-Yu Li, et al.
Published: (2023-05-01)

The Efficacy and Safety of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis
by: Lijun Wang, et al.
Published: (2022-04-01)

Comparative efficacy Shengxuening and polysaccharide iron complex treatment of anemia in patients with peritoneal dialysis
by: SHI Shao-hua, et al.
Published: (2015-01-01)

Resorption and tolerance of the high doses of ferrous sulfate and ferrous gluconate in the patients on peritoneal dialysis
by: Laušević Mirjana, et al.
Published: (2006-01-01)

Plasma phospholipids profiling changes were associated with the therapeutic response to Roxadustat in peritoneal dialysis patients
by: Ya-Hui Yang, et al.
Published: (2023-12-01)

The Roxadustat (FG-4592) ameliorates tubulointerstitial fibrosis by promoting intact FGF23 cleavage
by: Jing Wang, et al.
Published: (2025-04-01)

Treatment of anemia of chronic kidney disease caused by ANCA associated vasculitis with roxadustat:one case report with a literature review
by: Xiao Xiang, et al.
Published: (2021-01-01)

Rapid Initiation of Peritoneal Dialysis by Automated Peritoneal Dialysis or Hemodialysis: A Randomized Clinical Trial
by: Qianying Zhang, et al.
Published: (2023-10-01)

Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study
by: Xuejie Zhang, et al.
Published: (2023-11-01)

The Efficacy and Safety of Roxadustat for the Treatment of Posttransplantation Anemia: A Randomized Study
by: Weiwei Kong, et al.
Published: (2024-06-01)

Cardiovascular Protective Effects of Oral Hypoxia Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat in the Treatment of Type 4 Cardiorenal-Anemia Syndrome: Protocol of a Randomized Controlled Trial
by: Yumin Wen, et al.
Published: (2022-04-01)

Construction and validation of a predictive model for the risk of peritoneal dialysis-associated peritonitis after peritoneal dialysis catheterization
by: Rong Dai, et al.
Published: (2023-09-01)

Case report: Roxadustat overdose in an anemia patient of chronic kidney disease: insight beyond insignificant consequence
by: Long-Guang Zhang, et al.
Published: (2024-08-01)

Research advances of roxadustat in the treatment of various diseases
by: Tian Qian-qian, et al.
Published: (2022-07-01)